Litcius/Paper detail

Anti-tumor immunity and ferroptosis of hepatocellular carcinoma are enhanced by combined therapy of sorafenib and delivering modified GO-based PD-L1 siRNAs

Zhiwei Li, Jiaqi Bu, Xinyu Zhu, Hao Zhou, Kaiqun Ren, Paul K. Chu, Limin Li, Xiang Hu, Xiaofeng Ding

2022Biomaterials Advances30 citationsDOI

Topics & Concepts

SorafenibSmall interfering RNACancer researchCytotoxic T cellHepatocellular carcinomaMedicineImmunologyChemistryPharmacologyBiologyCell cultureTransfectionGeneticsIn vitroBiochemistryNanoplatforms for cancer theranosticsGraphene and Nanomaterials ApplicationsCancer Immunotherapy and Biomarkers
Anti-tumor immunity and ferroptosis of hepatocellular carcinoma are enhanced by combined therapy of sorafenib and delivering modified GO-based PD-L1 siRNAs | Litcius